Alice Melão

High levels of blood cholesterol may decrease the risk of men developing Parkinson’s disease, according to a large-scale clinical study.

A new process to select and purify stem cells that hold therapeutic potential to replace dopamine-producing neurons may hasten clinical…

An analysis of the protein content in tears may offer a non-invasive and inexpensive way of identifying people with probable…

Nilotinib can modulate dopamine levels and metabolism, as well as prevent the formation of toxic alpha-synuclein aggregates, according to…

The 2018 Science & PINS Prize for Neuromodulation was awarded to Nir Grossman, PhD, for his research to stimulate…

Cantabio Pharmaceuticals’ small molecule therapeutic candidate was able to protect dopamine-producing brain cells from death and prevent the loss of…

The European Medicines Agency (EMA) endorsed an imaging test that can help in identifying Parkinson’ patients with early stage disease…

Longevity Biotech announced plans for a clinical study aiming to identify potential blood-based markers of inflammation that originates in the…

Neuraly announced it has raised $36 million to advance its lead candidate NLY01 into clinical testing as a potential disease-modifying…

Cardiovascular damage in Parkinson’s patients, due to nerve cell loss in the heart, can be captured by imaging stress and…